Use of Topical sRAGE in Diabetic Wounds Increases Neovascularization and Granulation Tissue Formation
Authors:
- James LeeJLJames Lee
- Alejandro ConejeroACAlejandro Conejero
- Anne Marie SchmidtASAnne Marie Schmidt
- Robert GrantRGRobert Grant
- Arnold BreitbartABArnold Breitbart
- 1 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 52 (5) , 519-521
Abstract
Advanced glycation end products (AGEs) accumulate in diabetic wounds as a result of the glycosylation of various proteins. Interaction of AGEs with the receptor for AGEs (RAGE) results in an exaggerated inflammatory response and compromised collagen production. These changes lead to impaired wound healing. A soluble form of RAGE (sRAGE) has been shown to bind AGEs and thereby blunt their pathogenetic effects. Using genetically diabetic C57BLks-db/db mice, the authors applied sRAGE topically to standardized full-thickness wounds to improve diabetic wound healing. They measured various parameters of wound healing such as neovascularization, reepithelialization, collagen formation, and granulation tissue area. Their results showed a statistically significant increase in granulation tissue area and microvascular density in the sRAGE group compared with untreated wounds. There was a trend toward a smaller epithelial gap in the sRAGE-treated group that did not reach statistical significance. The authors conclude that sRAGE may be a powerful treatment of accelerating diabetic wound healing.Keywords
This publication has 11 references indexed in Scilit:
- Wound healing and diabetes mellitusClinics in Plastic Surgery, 2003
- RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic diseaseCellular and Molecular Life Sciences, 2002
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJournal of Clinical Investigation, 2001
- Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic MiceThe American Journal of Pathology, 2001
- The biology of the receptor for advanced glycation end products and its ligandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- Activation of Receptor for Advanced Glycation End ProductsCirculation Research, 1999
- β2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblastsKidney International, 1998
- Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994